Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:18 AM
Ignite Modification Date:
2025-12-25 @ 2:18 AM
NCT ID:
NCT03371134
Eligibility Criteria:
Inclusion Criteria:
* Sarcopenic patients (measured by DXA) affected by hip osteoarthritis, developmental dysplasia of the hip or hip fracture and undergoing hip replacement surgery (for the sarcopenic group)
* Patients affected by traumatic ACL tears and undergoing ACL reconstruction surgery (for the control group)
* Patients between 18 and 35 years old (for the control group)
* Patients between 65 and 90 years old (for the sarcopenic group)
* 18 ≤ Body Mass Index (BMI) ≤ 30 kg/m2
Exclusion Criteria:
* Diseases that can affect bone or muscle metabolism
* Pharmacological therapies that can interact with bone or muscle metabolism
* Bone metastases
* Bone infections
* HIV, hepatitis B virus, hepatitis C virus or Treponema pallidum positivity
* BMI ≥30kg/m2
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
90 Years
Study:
NCT03371134
Study Brief:
Protocol Section:
NCT03371134